InsidersTradesSigma
Browse the complete record of transactions filed by 남기연, Chairman & CEO. Director active across 2 companies, notably 큐리언트. Aggregated, 1 reports have been published. History available since 25 March 2026. The latest transaction was filed on 25 March 2026 (Purchase). Regulator: DART (FSS). The full history is openly available.
1 of 1 declaration
Nam Ki-yeon is the Chairman & CEO of Curient, an innovative company in the biotechnology sector. Under his leadership, Curient focuses on developing advanced therapeutic solutions. His expertise in management and product development is crucial to the company's mission of transforming healthcare.